In late August, the federal government predicted a limited amount of COVID-19 vaccines would be available at the beginning of November, and that healthcare systems in all 50 states should be ready to implement an inoculation plan by this date. However, only targeted populations will be eligible for receipt – begging the questions: who should be immunized first, and how should existing epidemiological data be used to help guide the decision-making process?
Big ideas. Better outcomes.
Fresh perspectives on clinical terminologies, code mapping, and patient insights from the experts at IMO.